Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.

Source:http://linkedlifedata.com/resource/pubmed/id/12698090

Transplantation 2003 Apr 15 75 7 1012-9

Download in:

View as

General Info

PMID
12698090